ULBP1 Protein (His-Avi Tag,Biotin)
-
- Target See all ULBP1 Proteins
- ULBP1 (UL16 Binding Protein 1 (ULBP1))
- Protein Type
- Recombinant
-
Origin
- Human
-
Source
- HEK-293 Cells
- Purification tag / Conjugate
- This ULBP1 protein is labelled with His-Avi Tag,Biotin.
- Sequence
- Gly26-Pro215
- Purity
- > 95% as determined by Tris-Bis PAGE,> 95% as determined by HPLC
- Sterility
- 0.22 μm filtered
- Endotoxin Level
- Less than 1EU per μg by the LAL method.
- Biological Activity Comment
- Immobilized Human NKG2D, hFc Tag at 2μg/ml (100μl/Well) on the plate. Dose response curve for Biotinylated Human ULBP-1, His Tag with the EC50 of 93.2ng/ml determined by ELISA. See testing image for detail.
- Top Product
- Discover our top product ULBP1 Protein
-
-
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Buffer
- Supplied as 0.22μm filtered solution in 20 mM PB, 0.5M NaCl, 0.1M L-arginine ( pH 8.0).
- Storage
- -80 °C
- Storage Comment
- Valid for 12 months from date of receipt when stored at -80°C. Recommend to aliquot the protein into smaller quantities for optimal storage. Please do not repeated freeze-thaw cycles.
- Expiry Date
- 12 months
-
- Target
- ULBP1 (UL16 Binding Protein 1 (ULBP1))
- Alternative Name
- ULBP-1 (ULBP1 Products)
- Synonyms
- RAET1I Protein, A430108B07Rik Protein, MULT1 Protein, ULBP1 Protein, UL16 binding protein 1 Protein, UL16 binding protein 21 Protein, NKG2D ligand 1 Protein, ULBP1 Protein, ULBP21 Protein, Ulbp1 Protein, LOC100683099 Protein
- Background
- ALCAN-beta, NKG2D ligand 1, N2DL-1, NKG2DL1, MULT-1, NKG2DL, AET1I, ULBP1, ULBP-1,Cell surface proteins major histocompatibility complex (MHC) class I-related chain A (MICA) and UL16-binding proteins (ULBP) 1, 2, and 3 are up-regulated upon infection or tumor transformation and can activate human natural killer (NK) cells.
- Molecular Weight
- 25.2 kDa. Due to glycosylation, the protein migrates to 28-35 kDa based on Tris-Bis PAGE result.
- UniProt
- Q9BZM6
- Pathways
- Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process
-